20 most expensive prescription drugs in 2021
08 Feb 2021
Drug prices in the U.S. are about 256 percent higher than those in other countries, according to recent research.
Below is a list of the 20 most expensive prescription drugs in the U.S., based on the official price their manufacture assigned to them, as compiled by prescription discount company GoodRx. This list excludes medications that must be administered by a healthcare practitioner.
Zokinvy (Eiger BioPharmaceuticals): $86,040
Myalept (Aegerion Pharmaceuticals): $74,159
Mavenclad (EMD Serono): $60,371
Ravicti (Horizon Therapeutics): $57,998
Actimmune (Horizon Therapeutics): $55,310
Oxervate (Dompé): $48,498
Takhzyro (Takeda): $46,828
Juxtapid (Aegerion Pharmaceuticals): $46,502
Cinryze (Takeda): $45,465
Chenodal (Travere Therapeutics): $42,570
Gattex (Takeda): $41,664
H.P. Acthar (Mallinckrodt Pharmaceuticals): $39,864
Orladeyo (BioCryst Pharmaceuticals): $37,308
Tegsedi (Akcea Therapeutics): $35,638
Ayvakit (Blueprint Medicines): $33,568
Vitrakvi (Bayer Pharmaceuticals): $32,800
Qinlock (Decipera Pharmaceuticals): $32,000
Korlym (Corcept Therapeutics): $31,440
Cerdelga (Genzyme): $28,599
Idhifa (Celgene): $28,246
Organizations
Indications
-Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.